Herpes simplex virus infection of the central nervous system in human immunodeficiency virus-type 1-infected patients

Grover, D.; Newsholme, W.; Brink, N.; Manji, H.; Miller, R.
September 2004
International Journal of STD & AIDS;Sep2004, Vol. 15 Issue 9, p597
Academic Journal
We report clinical, radiological and virological data from nine consecutive HIV-infected patients with herpes simplex virus (HSV) infection of the central nervous system (CNS). Three patients presented with confusion, two with fever and headache, two with anxiety and depression, one with slow mentation and memory loss and one with expressive dysphasia. Five patients had previous AIDS-defining diagnoses: four of these five patients had previous cutaneous HSV infection. HSV DNA was detected by the polymerase chain reaction (PCR) on cerebrospinal fluid (CSF) in seven patients. HSV infection was diagnosed by brain biopsy (after negative PCR on CSF) in one patient and at autopsy in one patient (after negative CSF PCR and brain biopsy). Seven patients received specific anti-viral therapy; two died of unrelated causes and the other five recovered. Two patients were not treated, in one the diagnosis was made at autopsy and the other recovered spontaneously. HIV-infected patients with CNS HSV infection have a varied presentation. Diagnosis by PCR on CSF identified the majority of cases. With specific treatment the outcome was good.


Related Articles

  • Nodular herpes simplex virus-1-positive oral lesions as a manifestation of immune reconstitution inflammatory syndrome. Briggs, A.; Kinghorn, G. R. // International Journal of STD & AIDS;May2010, Vol. 21 Issue 5, p377 

    We describe a case of nodular oral herpes simplex virus-1-positive lesions consistent with immune reconstitution inflammatory syndrome in a patient recently commenced on treatment for tuberculosis and HIV co-infection.

  • Recent Developments in the Management of Herpes Simplex Virus Infection in HIV-Infected Persons. Bartlett, John G. // Clinical Infectious Diseases;11/1/2004 Supplement, Vol. 39, pS237 

    The article discusses recent developments in the management of herpes simplex virus infection in HIV-infected persons. Herpes simplex virus (HSV) and HIV have certain common features, including persistence, stigma, and treatment that effectively decreases viral replication but cannot achieve...

  • High Incidence of Genotypic Variance between Sequential Herpes Simplex Virus Type 2 Isolates from HIV-1--Seropositive Patients with Recurrent Genital Herpes. Roest, R. Wim; Maertzdorf, Jeroen; Kant, Marius; van der Meijden, Willem I.; Osterhaus, Albert D. M. E.; Verjans, Georges M. G. M. // Journal of Infectious Diseases;10/15/2006, Vol. 194 Issue 8, p1115 

    We developed a polymerase chain reaction (PCR) method, based on strain-to-strain variation of DNA repeats in the herpes simplex virus type 2 (HSV-2) genes US1 and US12, to genotype HSV-2 strains and determine the incidence and risk factors associated with HSV-2 superinfection in patients with...

  • Antiviral Briefs.  // AIDS Patient Care & STDs;Mar2009, Vol. 23 Issue 3, p219 

    The article offers information of antiviral updates. U.S. Food and Drug Administration (FDA) was given a tentative approval to a fixed-dose combination tablet that contains three antiretrovirals stavudine, lamivudine, and nevirapine. Researchers at the Stanford University School of Medicine in...

  • Frequent Reactivation of Herpes Simplex Virus among HIV-1--Infected Patients Treated with Highly Active Antiretroviral Therapy. Posavad, Christine M.; Wald, Anna; Kuntz, Steven; Huang, Meei Li; Selke, Stacy; Krantz, Elizabeth; Corey, Lawrence // Journal of Infectious Diseases;8/15/2004, Vol. 190 Issue 4, p693 

    The effect of highly active antiretroviral therapy (HAART) on control of herpes simplex virus (HSV) in human immunodeficiency virus (HIV) type 1-infected subjects is not known. Among 28 HAART-treated and 49 untreated subjects with HIV-1 and HSV-2 infections, mucosal HSV shedding (median, 18% and...

  • Hsv infections in aids patients: need for awareness!!! Bhosale, Uday; Devi, V. Kusum; Jain, Nimisha // International Journal of PharmTech Research;Jan2009, Vol. 1 Issue 1, p101 

    Herpes simplex virus (HSV) has affected more that one third of the world's population and in India it is believed that 60% of sexually active adults carry herpes viruses. Approximately 45 million people in the US have HSV infections-about one in 5 people over the age of twelve. Sever persistent...

  • Topical microbicide based on siRNA. Flemming, Alexandra // Nature Reviews Drug Discovery;Jan2006, Vol. 5 Issue 1, p19 

    The article offers information on a study that discovered a treatment for sexually transmitted herpes simplex virus-2 (HSV-2) which causes infections that result in a significant morbidity, and is an important cofactor in the global spread of human immunodeficiency virus (HIV). The study...

  • Independent Nurse: Clinical - Sexual health - Controlling genital herpes - Infection. Bickford, Jane // GP: General Practitioner;1/20/2006, p104 

    The article presents information about genital herpes. Human herpes simplex virus is the most common cause of genital ulceration in Great Britain. In countries where HIV is more common, genital ulcerative disease is an important factor to consider with respect to HIV transmission. Genital herpes...

  • Resistance of Herpes Simplex Virus Infections to Nucleoside Analogues in HIV-Infected Patients. Levin, Myron J.; Bacon, Teresa H.; Leary, Jeffry J. // Clinical Infectious Diseases;11/1/2004 Supplement, Vol. 39, pS248 

    Antiviral treatment of herpes simplex virus (HSV) infections with nucleoside analogues has been well established for >2 decades, but isolation of drug-resistant HSV from immunocompetent patients has remained infrequent (0.1%-0.7% of isolates) during this period. Even when drug-resistant HSV is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics